Breaking Update: Sierra World Equity Review forecasts that Arena Pharmaceuticals (ARNA) stock price will start moving back up sharply on Monday. Despite all the AMAZING things going on for Arena, Sierra World Equity Reviews complex blend of Japanese technical indicators are all SCREAMING that this stock is going to move up to it's next leg. We like call things FIRST here on Sierra World Equity Review....many GREAT days coming for ARNA shareholders.
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
Saturday, June 30, 2012
Apple (AAPL), Nanotechnology and Space Elevators - Apple on the Cutting Edge of Science
Apple's amazing innovative and cutting edge technologies will be used in the development of the world's first Space Elevator ventures Sierra World Equity Review. Those who think that Apple is expensive at $584 per share today have no idea how valuable Apple will become as it becomes an integral part in the development and application of Nanotechnology and in so doing in the future destiny on mankind!
Plans for Space Elevators entail constructing a cable leading from earth to Earth's orbit using carbon nanotubes as the material. Electric lifts would then run the length of the cable. The lightweight durability of carbon nanotubes makes them a likely material for constructing the satellites and space stations that will ride the lift.
Japanese scientists and their American counterparts have been working furiously to push the development of the Space Elevator from science fiction to reality. Carbon nanotube technology is advancing faster than projected, according to the chairman of the Japan Space Elevator Association it'd only need to be four times stronger than the current strongest nanotube rope. Apple's cutting edge technologies will be a key component of the development of the Space Elevator... and the value of Apple will reflect it!
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
Plans for Space Elevators entail constructing a cable leading from earth to Earth's orbit using carbon nanotubes as the material. Electric lifts would then run the length of the cable. The lightweight durability of carbon nanotubes makes them a likely material for constructing the satellites and space stations that will ride the lift.
Japanese scientists and their American counterparts have been working furiously to push the development of the Space Elevator from science fiction to reality. Carbon nanotube technology is advancing faster than projected, according to the chairman of the Japan Space Elevator Association it'd only need to be four times stronger than the current strongest nanotube rope. Apple's cutting edge technologies will be a key component of the development of the Space Elevator... and the value of Apple will reflect it!
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
Cannabis Science Inc. to JV with GW Pharmaceuticals
Sierra World Equity Review is of the opinion that Cannabis Science will be teaming up in a joint venture with GW Pharmaceuticals of the United Kingdom. Sierra World Equity Review believes that Cannabis Science is undertaking aggressive research in the use of cannabis as part of an effective treament in the fight against AIDS. Recently the company appointed Mariel Selbovitz , MPH as Vice President of Research
Program Development at Cannabis Science. Cannabis Science has recently expanded its therapeutic indication
focus to include HIV with the initiation of the CS-TATI-1 research and
development program for a phytocannabinoids-based HIV-1 Tat inhibitor. Ms. Selbovitz will assist in design of preclinical and early stage
protocol development, facilitate collaborative research and development
agreements, interaction with NIH Office of Technology Transfer ,
interface with government sponsored clinical research programs on an
international scale.
That is where GW Pharmaceuticals of the United Kingdom comes into play, the company is already in advanced clinical trials for the world's first pharmaceutical developed from raw marijuana instead of synthetic equivalents, a mouth spray (Sativex) it hopes to market in the U.S. as a treatment for cancer pain. Sierra World Equity Review anticipates FDA approval by the end of 2013. Sativex is a whole plant medicinal cannabis extract indicated for the relief of multiple sclerosis (MS) symptoms and the treatment of severe neuropathic-related cancer pain. With GW Pharmaceuticals have focused on multiple sclerosis, Cannabis Science is focusing on AIDS. The benefits for both companies would be incredible, already GW Pharmaceuticals has given Bayer the exclusive rights to distribute Sativex in Europe, working with GW Pharmaceuticals on an phytocannabinoids-based HIV-1 Tat inhibitor drug would open all of GW Pharmaceuticals established markets to Cannabis Science.
Sierra World Equity Review will continue to highlight Cannabis Science and GW Pharmaceuticals going forward.
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
That is where GW Pharmaceuticals of the United Kingdom comes into play, the company is already in advanced clinical trials for the world's first pharmaceutical developed from raw marijuana instead of synthetic equivalents, a mouth spray (Sativex) it hopes to market in the U.S. as a treatment for cancer pain. Sierra World Equity Review anticipates FDA approval by the end of 2013. Sativex is a whole plant medicinal cannabis extract indicated for the relief of multiple sclerosis (MS) symptoms and the treatment of severe neuropathic-related cancer pain. With GW Pharmaceuticals have focused on multiple sclerosis, Cannabis Science is focusing on AIDS. The benefits for both companies would be incredible, already GW Pharmaceuticals has given Bayer the exclusive rights to distribute Sativex in Europe, working with GW Pharmaceuticals on an phytocannabinoids-based HIV-1 Tat inhibitor drug would open all of GW Pharmaceuticals established markets to Cannabis Science.
Sierra World Equity Review will continue to highlight Cannabis Science and GW Pharmaceuticals going forward.
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
Friday, June 29, 2012
Pfizer is already talking to Arena Pharmaceuticals trying to beat Johnson and Johnson and Bristol Myers Squibb to the punch ventures Sierra World Equity Review
Sierra World Equity Review ventures that Pfizer (PFE) is already talking to Arena Pharmaceuticals (ARNA) as it try's to cement another buyout before Johnson and Johnson and Bristol Myers Squibb (BMY) throw their names in the hat.
Both Bristol Meyers Squibb and Johnson and Johnson (JNJ) have huge cash reserves and could easily spoil any of Pfizer's acquisition plans. Sierra World Equity Review is of the opinion that it is critical for Pfizer to make this play on Arena Pharmaceuticals. Despite the Pfizer Wyeth deal," Wyeth's Prevnar and Enbrel will not be enough to replenish its research pipeline or replace Lipitor. Though Wyeth's Prevnar and Enbrel are expected to benefit Pfizer by softening the loss incurred due to the Lipitor patent expiry, the deal may not add the expected value as imagined by Pfizer."
A recent report about patent expiration from PricewaterhouseCoopers, Pharma 2020 is very alarming for the major players in the pharmaceutical industry... there are estimates that generic erosion will knock between two percent and 40 percent off the revenues of the top 10 companies between now and 2015.
"To add to the industry's woes, President Obama's plan for healthcare aims to lower drug costs by allowing the importation of safe medicines from other developed countries, increasing the use of generic drugs in public programs and taking on drug companies that block cheaper generic medicines from the market. Obama has also hinted that he will allow Medicare to negotiate directly with drug groups, as opposed to the current arrangement of companies dealing with smaller organizations. Obama's team claims this could drive down prices by up to 40 percent." - Marie Shields NGP magazine.
Sierra World Equity Review is very confident and will be the first to call this, in our opinion, Pfizer and Arena Pharmaceuticals are already talking!
We will continue to highlight Arena Pharmaceuticals and Pfizer going forward.
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
AWESOME things like a $50 PPS coming soon to Vringo Inc. involving Google
Sierra World Equity Review is forecasting that Vringo Inc (VRNG) will become at least a $50 stock when all is said and done with the patent lawsuit between Vringo and Google (GOOG). Shareholders in Vringo should be grinning from ear to ear, Sierra World Equity Review projects that they will win this lawsuit and be rewarded with a massive amount of money. So much money that we are also predicting that it is highly likely that when Google realizes that are going to lose it might be cheaper for them to simply buyout Vringo. It's all very interesting especially if you are a Vringo shareholder you should be ecstatic, either way the stock price is going to $50 or beyond in our opinion.
We will continue to highlight Vringo and Google going forward.
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
All American Pet Company (AAPT) is THE STOCK OF THE YEAR!
Ok, so AAPT has been in a downward trend lately as shareholders grow impatient of no official PR's from the company. Well Sierra World Equity Review has been in contact with management of AAPT sending out e-mails/phone calls trying to get a handle on what is going on.....and we are THRILLED at our interpretation what is coming. Sierra World Equity Review is of the opinion that soon the company will release detailed information about it's upcoming triple product release to retail outlets which including a new pet wellness bar.
For full disclosure Sierra World Equity Review has had a long position in the company for many months, we intend to maintain that position and increase our position on dips.
Sierra World Equity Review would also like to set the record straight, on some stocks boards it has been suggested that our site is not in the United States, it has been said that we are shorting the stock or that we have some hidden agenda. Sierra does not normally respond to false allegations but we have observed a group of very loyal long supporters of AAPT and so in their best interest we say....ALL accusations are FALSE! PERIOD!
Sierra World Equity Review holds a long position, an investment position, we intend to add to our position on dips and never short All American Pet Company.
We are VERY GOOD at what we do and we have NEVER seen a pennystock like AAPT, It is a pennystock in name only. Massive things are ahead for All American Pet Company.
WE are also not compensated or in any way part of the workings of the inner circle of AAPT management!
Hope that clears everything up....go AAPT!!
For full disclosure Sierra World Equity Review has had a long position in the company for many months, we intend to maintain that position and increase our position on dips.
Sierra World Equity Review would also like to set the record straight, on some stocks boards it has been suggested that our site is not in the United States, it has been said that we are shorting the stock or that we have some hidden agenda. Sierra does not normally respond to false allegations but we have observed a group of very loyal long supporters of AAPT and so in their best interest we say....ALL accusations are FALSE! PERIOD!
Sierra World Equity Review holds a long position, an investment position, we intend to add to our position on dips and never short All American Pet Company.
We are VERY GOOD at what we do and we have NEVER seen a pennystock like AAPT, It is a pennystock in name only. Massive things are ahead for All American Pet Company.
WE are also not compensated or in any way part of the workings of the inner circle of AAPT management!
Hope that clears everything up....go AAPT!!
We will continue to highlight
All American Pet Company going forward.
Sierra World Equity Review currently holds a long position in All American Pet Company.
Breaking News - Is Apple (AAPL) to announce buyout of Research In Motion (RIMM)
Sierra World Equity Review is on the cutting edge of accurate news for all it's readers. Sierra World Equity Review is now predicting an announcement from Apple about a buyout of Research In Motion (RIMM). Sierra believes that RIMM will surprise shareholders with increased sales and stronger than expected cash reserves in the coming months contrary to what other analysts are predicting. This is still a breaking story...check back here for updates.
We will continue to highlight Apple and Research In Motion and going forward.
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
Thursday, June 28, 2012
VRINGO (VRNG) stock to soar says Sierra World Equity Review
Sierra World Equity Review the new phenom in accuracy, forecasting and reporting is predicting that the shareholders of Vringo Inc. (VRNG) should be EXTREMELY happy right now.
Sierra ventures that they have found themselves in stock that is going nowhere but UP, way UP!
With Vringo just being added to the Russell Microcap Index the company will receive a huge amount of new exposure from institutional investors bringing in the big money. With Vringo also wrapping up it's proposed merger withInnovate/Protect, Inc things are looking rosy to say the least. HOWEVER, the single most significant news is that the marketplace around the world for high speed internet and smart phones just keeps EXPLODING! As an innovative leader in the technology sector Vringo will see it's revenue streams soar as the company capitalizes on this globally especially in the emerging nations.
So these are good times for Vringo and it's shareholder and they will only get BETTER!
Sierra ventures that they have found themselves in stock that is going nowhere but UP, way UP!
With Vringo just being added to the Russell Microcap Index the company will receive a huge amount of new exposure from institutional investors bringing in the big money. With Vringo also wrapping up it's proposed merger with
So these are good times for Vringo and it's shareholder and they will only get BETTER!
We will continue to highlight Vringo going forward.
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
SIERRA WAS CORRECT AGAIN!!.....we said yesterday Bebida Beverage Co. (BBDA) share price was going to CRASH and it DID!
So we NAILED it AGAIN, yesterday we forecast that Bebida Beverage Co (BBDA) pps would crash hard. Today it dropped 37.04%. Are we good or what!
Expect the suffering to continue tomorrow, as soon as it looks like a reversal we will also share that with you.
Remember once again you heard it here FIRST, Sierra World Equity Review!
We will continue to highlight Bebida Beverage Co going forward.
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
How Pfizer just got saved by Arena Pharmaceuticals
Ok, well that's an exaggeration of course.
Sierra World Equity Review is of the opinion though that once the FDA approval for Belviq came out, the executives at Pfizer World Headquarters in mid town Manhatten were already crunching the numbers. No-one really can truthfully say just how big the obesity drug market for Belviq will be, but everyone agrees it is MASSIVE and with obesity rates continuing to escalate Belviq will be like a cash ATM just spitting out non-stop incredible revenue streams for whomever it the patent holder. Right now Arena Pharmaceuticals staff and management along with it's shareholders are all giddy with delight, as the accomplishment of having the first weight loss obesity drug approved in over a decade starts to sink in.
While the stock price has not risen to the level many had hoped after trading resumed after approval, Sierra World Equity Review forecasts that it will slowly start to climb to new heights. Sierra World Equity Review is also firmly of the conviction that Pfizer will soon be dangling the purse strings in front of Arena Pharmaceuticals. Today Pfizer declared a 22-cent third-quarter 2012 dividend on the
company's common stock, payable September 5, 2012 , to
shareholders of record at the close of business on August 3, 2012 . Pfizer has deep pockets and you can be sure that Arena Pharmaceuticals will not come cheap.....shareholders of both companies stand to mutually benefit!
We will continue to highlight Arena Pharmaceuticals and Pfizer going forward.
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
Arena Pharmaceuticals IS the HOTTEST pharmaceutical of the YEAR!
Despite closing down approximately 10% today Sierra World Equity review maintains it's forecast that Arena Pharmaceuticals is going to become the hottest BUYOUT candidate in the pharmaceutical industry this year.
With it's new obesity weight loss drug Belviq being approved by the FDA, (the first time in over a decade that one has been approved), and Arena Pharmaceuticals to promote Belviq's approval internationally the sky's the limit.
Sierra World Equity Review was the first to state that the company would start receiving upgrades, today Jefferies raised it's forecast from $9 to $20. Sierra World Equity Review feels that this is even too conservative when you factor in the massive market for a FDA approved obesity weight loss drug.
More to follow......about the Pfizer buyout that Sierra World Equity Review forecasts is coming. Please check back.
With it's new obesity weight loss drug Belviq being approved by the FDA, (the first time in over a decade that one has been approved), and Arena Pharmaceuticals to promote Belviq's approval internationally the sky's the limit.
Sierra World Equity Review was the first to state that the company would start receiving upgrades, today Jefferies raised it's forecast from $9 to $20. Sierra World Equity Review feels that this is even too conservative when you factor in the massive market for a FDA approved obesity weight loss drug.
More to follow......about the Pfizer buyout that Sierra World Equity Review forecasts is coming. Please check back.
We will continue to highlight Arena Pharmaceuticals and Pfizer going forward.
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
YIKES....Bebida Beverage Co. (BBDA) share price is going to CRASH!
Sierra World Equity Review anticipates that Bebida Beverage Co (BBDA) share price will very soon dump!
All of our excellent and accurate technical indicators are SCREAMING THIS. Watch for official PRs to start flowing to stem the selling once it starts, we would not touch this stock with a ten foot pole right now!
We realize this is not the news shareholders like to hear but we are of the opinion that it is ACCURATE.
Sierra World Equity Review is very accurate in it's projections based upon an awesome combination of technical analysis that involves some amazing Japanese indicators.
All of our excellent and accurate technical indicators are SCREAMING THIS. Watch for official PRs to start flowing to stem the selling once it starts, we would not touch this stock with a ten foot pole right now!
We realize this is not the news shareholders like to hear but we are of the opinion that it is ACCURATE.
Sierra World Equity Review is very accurate in it's projections based upon an awesome combination of technical analysis that involves some amazing Japanese indicators.
Remember once again you heard it here FIRST, Sierra World Equity Review!
We will continue to highlight Bebida Beverage Co going forward.
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
IC Places (ICPA) is this stock going to take off like a rocket when it goes INTERNATIONAL!!
Sierra World Equity Review projects that IC Places (ICPA) has something very special lined up for it's investors. Sierra World Equity Review ventures that it is just a matter of time before the company releases an official PR about ICPA going international starting in Europe and then spreading into Asia with the big prize being China. Sierra World Equity Review is of the opinion that management at ICPA is keeping this one close to their chests. The talented people running ICPA has done a terrific job in getting ICPA to where it is, often in pennyland PR's flow faster than the speed of light as inferior companies attempt to elevate themselves. NOT the case here, Sierra World Equity Review believes that when the time is right the company will release news about going international that will make it's shareholders giddy with delight. Great things are coming to ICPA in Sierra's opinion.
Remember once again you heard it here FIRST, Sierra World Equity Review!
We will continue to highlight IC Places going forward.
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
Wednesday, June 27, 2012
UPDATE is Arena Pharmaceuticals to be bought out by Pfizer - LIFE AFTER APPROVAL
Sierra World Equity Review was the FIRST to make the call that Lorcaserin (now Belviq) would get FDA approval, in fact we felt so good about it that we made the call days ago and put it out their with our good name attached. We are VERY GOOD at what we do!
Ok, so now that we have tooted our own horn, lets move on to what will happen next!
Sierra World Equity Review projects the share price of Arena Pharmaceuticals ARNA to keep steadily moving up, There is a GARGANTUAN market out their waiting for Belviq, the pps of the company will be driven by earnings and future potential earnings which will be massive. For those dissappointed with the share price not being hit out of the ball park today after FDA gave approval....DO NOT WORRY....it is only going to get better from here.
Ok, so now that we have tooted our own horn, lets move on to what will happen next!
Sierra World Equity Review projects the share price of Arena Pharmaceuticals ARNA to keep steadily moving up, There is a GARGANTUAN market out their waiting for Belviq, the pps of the company will be driven by earnings and future potential earnings which will be massive. For those dissappointed with the share price not being hit out of the ball park today after FDA gave approval....DO NOT WORRY....it is only going to get better from here.
Sierra World Equity Review forecasts that ARNA will soon have a famous TV personality who has battled obesity promoting Belvig as the promotion and advertising campaign kicks in.
However most importantly Sierra World Equity Review ventures that Pfizer (PFE) will buyout Arena Pharmaceuticals within the next 6 month! Expect to see the share price of Pfizer start to climb as it looks to get it's hands on the first obesity weight loss drug approved in over a DECADE. With patents of it's own running out and those huge revenue earners not being replaced by new products it make excellent financial sense for Pfizer to continue it's pattern of buying out small pharmaceutical companies that have shown promise or had success with the FDA.
Sierra World Equity Review also believes that the very strong possibility exists for a bidding war if more than one of the major players in the industry like Johnson & Johnson (JNJ) and Bristol-Myers Squibb (BMY) also throw their names in the hat.
So Arena Pharmaceuticals and it's shareholders are in a wonderful position and should have a fantastic rest of the year.
Remember once again you heard it here FIRST, Sierra World Equity Review!
We will continue to highlight Arena Pharmaceuticals and Pfizer going forward.
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
CONGRATULATIONS Arena Pharmaceuticals ARNA on approval of Lorcaserin....Sierra World Equity Review called it FIRST!
Sierra World Equity Review once again demonstrated that it is awesome in making the most ACCURATE calls. Sierra made the approval call days ago, just look at the previous opinions we issued.
HOWEVER, Sierra says that this is only just the beginning of awesome things for Arena Pharmaceuticals and it's shareholders. If you are interested in what is next in store for Arena Pharmaceuticals check back here later tonight, we are putting together a piece that will make the shareholders giddy with delight, read our next opinion.....coming later this evening.
Check back often for all the scoop on many of the hottest stocks on the market.
Sierra World Equity Review is an independent source of information and opinion and hold no positions in Arena Pharmaceuticals
HOWEVER, Sierra says that this is only just the beginning of awesome things for Arena Pharmaceuticals and it's shareholders. If you are interested in what is next in store for Arena Pharmaceuticals check back here later tonight, we are putting together a piece that will make the shareholders giddy with delight, read our next opinion.....coming later this evening.
Check back often for all the scoop on many of the hottest stocks on the market.
Sierra World Equity Review is an independent source of information and opinion and hold no positions in Arena Pharmaceuticals
UPGRADE: Arena Pharmaceuticals ARNA -Sierra World Equity Review has upgraded ARNA
Sierra World Equity Review, the leader in cutting edge news is the FIRST to make the call that Arena Pharmaceuticals will be UPGRADED! We have already UPGRADED ARNA!
Following today's anticipated approval by the FDA of the obesity weight loss drug Lorcaserin Sierra World Equity Review is delighted to be the FIRST to make that call. Sierra World Equity Review is an independent source of information and hold no positions in ARNA
Following today's anticipated approval by the FDA of the obesity weight loss drug Lorcaserin Sierra World Equity Review is delighted to be the FIRST to make that call. Sierra World Equity Review is an independent source of information and hold no positions in ARNA
Arena Pharmaceuticals ARNA, IC Places ICPA, Bebida Beverage Co. (BBDA), Agr Tools (QB) (AGRT), Great Wall Builders (GWBU) and Cannabis Science Inc. (CBIS) ---INFORMATION you should know for this week!
Sierra World Equity Review is happy to share with you our opinions through some short blurbs on what to look for this week with the following stocks.
-Arena Pharmaceuticals ARNA - obesity weight loss drug Lorcaserin will get approved this week by the FDA. Stock price to SOAR!
-IC Places ICPA - has a definite agenda to expand overseas, first to Europe and then Asia, we'd touched on this in an earlier piece but will revisit it with some exciting info for the shareholders. Please check back later this week.
-Bebida Beverage Co. BBDA - Shareholders should be VERY WARY! This stock is going to tank this week, look for official PR's to try stop the bleeding.
-Agr Tools (QB) AGRT - GOOD week ahead for the stock as it rebounds. We have a nice piece we are putting together on the company, please check back later this week.
-Great Wall Builders GWBU - YIKES! Once again shareholder should be VERY WARY! This stock is going to continue going down the tubes despite money still coming into it.....do not get caught holding the bag!
-Cannabis Science Inc. CBIS - Light one up for CBIS! We will be doing a great piece this week that should make all the shareholders very happy, please check back as we are still working on it.
-Arena Pharmaceuticals ARNA - obesity weight loss drug Lorcaserin will get approved this week by the FDA. Stock price to SOAR!
-IC Places ICPA - has a definite agenda to expand overseas, first to Europe and then Asia, we'd touched on this in an earlier piece but will revisit it with some exciting info for the shareholders. Please check back later this week.
-Bebida Beverage Co. BBDA - Shareholders should be VERY WARY! This stock is going to tank this week, look for official PR's to try stop the bleeding.
-Agr Tools (QB) AGRT - GOOD week ahead for the stock as it rebounds. We have a nice piece we are putting together on the company, please check back later this week.
-Great Wall Builders GWBU - YIKES! Once again shareholder should be VERY WARY! This stock is going to continue going down the tubes despite money still coming into it.....do not get caught holding the bag!
-Cannabis Science Inc. CBIS - Light one up for CBIS! We will be doing a great piece this week that should make all the shareholders very happy, please check back as we are still working on it.
Tuesday, June 26, 2012
Will Arena Pharmaceuticals (ARNA) sign famous former TV Personality after Lorcaserin Approval Today
Sierra World Equity Review predicts that Arena Pharmaceuticals will move quickly with it's advertising campaign after it receives approval Wednesday from the FDA for it's obesity drug Lorcaserin.
Sierra World Equity Review ventures that the company will hire a famous former TV personality who has personally battled obesity problems to promote Lorcaserin to the public. Expect the official PR's to start flowing as the company ratchets into high gear. Also look for that share price to go into high gear as well:)
Remember you heard it hear first, Sierra World Equity Review has it's finger on the pulse of the action. Have a wonderful day shareholders of ARNA.....days like this do not come very often. ENJOY!
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
Sierra World Equity Review ventures that the company will hire a famous former TV personality who has personally battled obesity problems to promote Lorcaserin to the public. Expect the official PR's to start flowing as the company ratchets into high gear. Also look for that share price to go into high gear as well:)
Remember you heard it hear first, Sierra World Equity Review has it's finger on the pulse of the action. Have a wonderful day shareholders of ARNA.....days like this do not come very often. ENJOY!
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
Breaking UPDATE Lorcaserin will be approved by the FDA predicts Sierra World Equity Review.
Sierra World Equity Review is of the opinion that the share holders of Arena Pharmaceuticals (ARNA) will be celebrating when Lorcaserin, an obesity weight loss drug gets final FDA approval.
Fda Food And Drug Administration Bumper Sticker
Fda Food And Drug Administration Bumper Sticker
Remember you heard it here FIRST! Already recommended for approval on May 10, 2012, by the FDA's advisory committee on an 18-4 vote today speculation and interpretation was that the minutes of the meeting were not positive and that "panelists reluctantly voted yes..."
Ridiculous says Sierra World Equity Review, the vote was not even close, and if you look through the chatter that's all it is NOISE! This is a drug that will have massive appeal and incredible sales, The FDA has rightly turned down other candidates left and right but never has one had the positive things going for it as does Lorcaserin.
This is a fantastic time to be a shareholder in ARNA and Sierra World Equity Review congratulates them on their foresight into getting into such a life changing stock.
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
Fda Food And Drug Administration Coffee Mug
Fda Food And Drug Administration Coffee Mug
Pfizer (PFE) legal team ready to go, documents drafted, C'mon FDA lets get it on!
Sierra World Equity Review ventures that Pfizer's legal team has already drafted the BUYOUT documents for Arena Pharmaceuticals (ARNA). Remember you heard it hear first!
"Pharmaceutical Technician For Apparel"
Everyone is now simply in a holding pattern awaiting the final approval from the FDA for Arena Pharmaceuticals obesity weight loss drug Lorcaserin.
Already recommended for approval on May 10, 2012, by the FDA's advisory committee on an 18-4 vote, the chances of receiving the final green light are fantastic as the FDA normally follows the advisory committee recommendations.
Check back for continuing updates, Sierra World Equity Review, the new phenom in stock information, commentary and accurate calls!
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
"Pharmaceutical Technician For Ipod Touch Cases"
"Pharmaceutical Technician For Apparel"
Everyone is now simply in a holding pattern awaiting the final approval from the FDA for Arena Pharmaceuticals obesity weight loss drug Lorcaserin.
Already recommended for approval on May 10, 2012, by the FDA's advisory committee on an 18-4 vote, the chances of receiving the final green light are fantastic as the FDA normally follows the advisory committee recommendations.
Check back for continuing updates, Sierra World Equity Review, the new phenom in stock information, commentary and accurate calls!
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
"Pharmaceutical Technician For Ipod Touch Cases"
Monday, June 25, 2012
Great Wall Builders (GWBU) is TOAST and going DOWN poor gullible shareholder do not be left holding the bag!
Great Wall Builders (GWBU) continues to see it's share price plummeting DOWN another 45.71% today.
Great Wall China Magnet
Sierra World Equity Review would not touch this stock with a 10 foot pole at this point! The gig is up for GWBU expect another huge sell off tomorrow! To all the faithful GWBU shareholders who in desperation watch as the value of their portfolio crumbles yet hope that somehow GWBU will rise again to it's former glory you are only deceiving yourselves. Take your profits OR minimize your losses before they get WORSE and get out.....that is what Sierra World Equity Review would do!
Sierra World Equity Review currently hold no positions in any of the GWBU and never will!
CET Domain SZ11-1092-10 Men's Great Wall of China Inspired Design Titanium Silver Ring-Size 10
Great Wall China Magnet
Sierra World Equity Review would not touch this stock with a 10 foot pole at this point! The gig is up for GWBU expect another huge sell off tomorrow! To all the faithful GWBU shareholders who in desperation watch as the value of their portfolio crumbles yet hope that somehow GWBU will rise again to it's former glory you are only deceiving yourselves. Take your profits OR minimize your losses before they get WORSE and get out.....that is what Sierra World Equity Review would do!
Sierra World Equity Review currently hold no positions in any of the GWBU and never will!
CET Domain SZ11-1092-10 Men's Great Wall of China Inspired Design Titanium Silver Ring-Size 10
SIRIUS XM Radio Inc. (SIRI) to get PUNISHED, SPANKED and BEATEN...stockholders BEWARE!
Sierra World Equity Review ventures that the good times have come and gone for SIRIUS XM Radio Inc. (SIRI). They have had their 15 minutes in the spotlight and now the gig is up as Liberty Media (LMCA) attempts to take majority control of the company.
"Siri Question Shirt"
Desperate to stave off Liberty Media, Sirius has filed with the Federal Communications Commission to thwart Liberty Media efforts. However Sierra World Equity Review believes that the writing is on the wall and with no clear game plan form Liberty Media on their agenda to run the company expect SIRI stock to start taking a beating. Sorry shareholders but it is true!
Sierra World Equity Review will continue to highlight SIRIUS XM Radio and Liberty Media going forward.
"Siri Question Shirt"
Desperate to stave off Liberty Media, Sirius has filed with the Federal Communications Commission to thwart Liberty Media efforts. However Sierra World Equity Review believes that the writing is on the wall and with no clear game plan form Liberty Media on their agenda to run the company expect SIRI stock to start taking a beating. Sorry shareholders but it is true!
Sierra World Equity Review will continue to highlight SIRIUS XM Radio and Liberty Media going forward.
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
"Keep Calm And Ask Siri Coffee Mug"
Is Research in Motion (RIMM) and Apple (AAPL) working on a Hot New Secret Joint Venture?
Sierra World Equity Review highlights Research in Motion and Apple possibly working together on new products.
Sierra World Equity Review ventures that despite today's downgrade Research in Motion (RIMM) has something special in the works. Research in Motion today denied speculation that they were splitting Research in Motion into two separate businesses, instead they reaffirmed the company is aggressively pursuing and committed to their current turnaround strategy and will soon be launching new products.
Sierra World Equity Review speculates that Apple, who has been quick and innovative in tapping into the excellent technology of smaller companies and that most companies and all service providers would do anything to work with Apple, has been working with Research in Motion for their mutual benefit. Stayed tuned for further updates as Sierra World Equity Review investigates this angle and will continue to highlight both Research in Motion and Apple Inc. going forward.
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
Let the NEXT Bidding War begin, Pfizer, Bristol-Myers Squibb & Johnson & Johnson looking at Arena Pharmaceuticals
Are Pfizer (PFE), Bristol-Myers Squibb (BMY) & Johnson & Johnson (JNJ) looking at Arena
Pharmaceuticals (ARNA) as their next acquisition in the lucrative obesity drug market.
Pfizer Ah 8112 8112 Resorb Pkts 64Gm 12- Dis
Sierra World Equity Review believes that one of these major players in the pharmaceutical industry are looking at buying out Arena Pharmaceuticals which is about to have it's obesity weight loss drug Lorcaserin hydrochloride approved by the FDA.
Sierra World Equity Review predicts that the FDA approval of Lorcaserin will make Arena Pharmaceuticals the hottest target of a buyout in the
pharmaceutical industry this year.
Sierra World Equity Review ventures that the very real possibility exists that a bidding war may develop if one or more of these major players,
Pfizer (PFE), Bristol-Myers Squibb (BMY), Johnson & Johnson (JNJ) move on Arena Pharmaceuticals. If that scenario were to unfold stockholders in Arena Pharmaceuticals would strike the proverbial jackpot!
Johnson's - Baby Lotion - 2 pk. - Baby Stock Up
Pfizer (PFE), Bristol-Myers Squibb (BMY), Johnson & Johnson (JNJ) move on Arena Pharmaceuticals. If that scenario were to unfold stockholders in Arena Pharmaceuticals would strike the proverbial jackpot!
Johnson's - Baby Lotion - 2 pk. - Baby Stock Up
Sierra World Equity Review forecasts that Arena Pharmaceuticals Lorcaserin will receive final FDA approval, the major players in the industry would certainly want a piece of that action, many have spent millions on research and development trying for an obesity weight loss drug without success. Arena Pharmaceuticals is about to gain massive value for itself at home and internationally. Top management at Arena Pharmaceuticals through innovative cutting edge research and development, careful planning, patent applications and showing fiscal responsibility by maximizing opportunities and revenues through domestic and international ventures have brilliantly placed Arena Pharmaceuticals in an amazing position.
Sierra World Equity Review speculates the company may take the first offer on the table and the PPS would shoot up, if a bidding war came about the PPS would become even more fantastic compared to the share price today! In either case the share holder is going to win and win big!
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
Sierra World Equity Review anticaptes that Oxigene (OXGN) to get Phase III FDA approval of ZYBRESTAT
Sierra World Equity Review is the FIRST to forecast that the FDA will grant approval for Phase III trials to Oxigene, new drug ZYBRESTAT, a vascular disrupting agent program for neuroendocrine cancers, focused specifically on carcinoid syndrome.
Sierra World Equity Review, the leader in small biotech stock analysis and the new phenom in stock selections is glad to be the FIRST to announce that we believe that Oxigene (OXGN) will get Phase III FDA approval of it's new drug ZYBRESTAT.
Sierra World Equity Review, the leader in small biotech stock analysis and the new phenom in stock selections is glad to be the FIRST to announce that we believe that Oxigene (OXGN) will get Phase III FDA approval of it's new drug ZYBRESTAT.
We feel VERY good about this call but wanted to get more confirmation before we went public, however in the interests of the shareholders and our cutting edge reputation as the leader in breaking news we decided to go public with our opinion NOW.
All American Pet Company (AAPT) is about to become current on it's filings- GREAT NEWS for it's shareholders!
Sierra World Equity Review predicts that All American Pet Company (AAPT) is about to become current on all it's necessary filings!
While this has been expected and anticipated the reality of it is VERY significant! All American Pet Company has it's patent pending PAWtizer already on sale on Amazon.com where it quickly moved up the best sellers list. With AAPT on the verge of rolling out it's products including a triple line up of innovative dog foods the company has aggressively looked to carve out it's share of the massive Pet Food and Pet Product industry. Sierra World Equity Review anticipates a scenario where AAPT introduces it's products into brick and mortar box stores across the country, becomes current in it's filings and then moves off the Pink sheets onto the big board.....not necessarily in that order! If that were not enough the company has already set in place the mechanism to go international....big things coming to the shareholders of AAPT!
Sierra World Equity Review holds a long position in All American Pet Company.
While this has been expected and anticipated the reality of it is VERY significant! All American Pet Company has it's patent pending PAWtizer already on sale on Amazon.com where it quickly moved up the best sellers list. With AAPT on the verge of rolling out it's products including a triple line up of innovative dog foods the company has aggressively looked to carve out it's share of the massive Pet Food and Pet Product industry. Sierra World Equity Review anticipates a scenario where AAPT introduces it's products into brick and mortar box stores across the country, becomes current in it's filings and then moves off the Pink sheets onto the big board.....not necessarily in that order! If that were not enough the company has already set in place the mechanism to go international....big things coming to the shareholders of AAPT!
Sierra World Equity Review holds a long position in All American Pet Company.
Sunday, June 24, 2012
BREAKING UPDATE: Sierra World Equity Review believes Pfizer(PFE) is looking at Arena Pharmaceuticals (ARNA) BUYOUT!
Sierra World Equity Review is always on the cutting edge of the latest industry news. Arena Pharmaceuticals is about to have it's obesity weight loss drug Lorcaserin approved this week. Look for Pfizer to makes it move!
Pfizer Ah 8112 8112 Resorb Pkts 64Gm 12- Dis
With it's cholesterol drug, Lipitor patent expired Pfizer is desperately trying to stem the loss of the huge revenues it had garnished for the company. They have been very active buying out four small biotech publicly traded companies in the last few years! They have also spent millions on research and development trying for an obesity weight loss drug without success.
Sierra World Equity Review predicts that Arena Pharmaceuticals will have it's obesity weight loss drug Lorcaserin hydrochloride approved this week by the FDA.
BarCharts- Inc. 9781423203025 Obesity- Adults- Pack of 3
Unfortunately, new drugs are not replacing expiring multi-billion dollar sellers. In fact, just the opposite is true, although it is not due to a lack of effort. For example, Pfizer spent years looking for a replacement for Lipitor, but the replacement candidate, torcetrapib, despite raising HDL, the so-called "good" cholesterol, actually increased death rates during clinical trials, and it was withdrawn. Hundreds of millions of research dollars went down the drain with it. Having failed in other attempts to replenish its pipeline through the discovery process, Pfizer took the "predator" route and bought Wyeth for its product line in 2009.
Thus it makes very good fiscal sense for a giant like Pfizer to move in and sweep up the small successful bio techs like
Arena Pharmaceuticals. BIG WINNERS in the equation will be all the shareholders of ARNA....good for you:)
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
Pfizer Ah 8112 8112 Resorb Pkts 64Gm 12- Dis
With it's cholesterol drug, Lipitor patent expired Pfizer is desperately trying to stem the loss of the huge revenues it had garnished for the company. They have been very active buying out four small biotech publicly traded companies in the last few years! They have also spent millions on research and development trying for an obesity weight loss drug without success.
Sierra World Equity Review predicts that Arena Pharmaceuticals will have it's obesity weight loss drug Lorcaserin hydrochloride approved this week by the FDA.
BarCharts- Inc. 9781423203025 Obesity- Adults- Pack of 3
Unfortunately, new drugs are not replacing expiring multi-billion dollar sellers. In fact, just the opposite is true, although it is not due to a lack of effort. For example, Pfizer spent years looking for a replacement for Lipitor, but the replacement candidate, torcetrapib, despite raising HDL, the so-called "good" cholesterol, actually increased death rates during clinical trials, and it was withdrawn. Hundreds of millions of research dollars went down the drain with it. Having failed in other attempts to replenish its pipeline through the discovery process, Pfizer took the "predator" route and bought Wyeth for its product line in 2009.
Thus it makes very good fiscal sense for a giant like Pfizer to move in and sweep up the small successful bio techs like
Arena Pharmaceuticals. BIG WINNERS in the equation will be all the shareholders of ARNA....good for you:)
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
Highline Technical Innovation (HLNT) stockholders about to get a reality check!
Sierra World Equity Review projects that the PPS of Highline Technical Innovation (HLNT) is about to undergo a correction.
Sierra World Equity Review is of the opinion that the rise of value of Highline Technical Innovation (HLNT) share price is over for the short term. Highline Technical Innovation has enjoyed a nice run BUT it is now completely overbought and Sierra's technical indicator blend are SCREAMING that the PPS is due for a correction. While not a reflection on the company itself expect the share price to fall and profit taking to begin.
Sierra World Equity Review is of the opinion that the rise of value of Highline Technical Innovation (HLNT) share price is over for the short term. Highline Technical Innovation has enjoyed a nice run BUT it is now completely overbought and Sierra's technical indicator blend are SCREAMING that the PPS is due for a correction. While not a reflection on the company itself expect the share price to fall and profit taking to begin.
With Highline Technical Innovation recently announcing that they have hired LaunchiT a public relations firm to promote the company expect PR after PR to try to stop the bleeding once the price starts to fall.
Back to reality for the share holders OF (HLNT)!!
Sierra World Equity Review currently holds no positions in Highline Technical Innovation (HLNT) and will continue to highlight the company with unbiased independent coverage moving forward.
Lorcaserin will get Final FDA Approval on this week, Value of Arena Pharmaceuticals (ARNA) to soar!
Sierra World Equity review predicts that Lorcaserin, an obesity weight loss drug from Arena Pharmaceuticals will receive final approval this week.
Sierra World Equity Review is confident that a new obesity weight loss drug Lorcaserin hydrochloride, will get the green light from the FDA this week.
PhysiciansCare 90186 Accutest Multi-Drug Screener Test Kit
Already recommended for approval on May 10, 2012, by the FDA's advisory committee on an 18-4 vote, the chances of receiving the final green light are fantastic as the FDA normally follows the advisory committee recommendations.
While much of the anticipated approval is already built into the stock price Sierra World Equity Review ventures that this is just the beginning for Arena Pharmaceuticals. They not only hold the patent on Lorcaserin in the United States but almost everywhere in Europe. With Esai, a Japan based distribution company lined up to have exclusive distribution rights the company has prepared well and laid the ground work for tremendous growth and success.
Hubbard Scientific R-101316 Effect of Drugs Lab Kit
Sierra World Equity Review anticipates the share price of Arena Pharmaceuticals to take off like a rocket again this week after approval leading to an amazing July for all the shareholders.
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
Sierra World Equity Review is confident that a new obesity weight loss drug Lorcaserin hydrochloride, will get the green light from the FDA this week.
PhysiciansCare 90186 Accutest Multi-Drug Screener Test Kit
Already recommended for approval on May 10, 2012, by the FDA's advisory committee on an 18-4 vote, the chances of receiving the final green light are fantastic as the FDA normally follows the advisory committee recommendations.
While much of the anticipated approval is already built into the stock price Sierra World Equity Review ventures that this is just the beginning for Arena Pharmaceuticals. They not only hold the patent on Lorcaserin in the United States but almost everywhere in Europe. With Esai, a Japan based distribution company lined up to have exclusive distribution rights the company has prepared well and laid the ground work for tremendous growth and success.
Hubbard Scientific R-101316 Effect of Drugs Lab Kit
Sierra World Equity Review anticipates the share price of Arena Pharmaceuticals to take off like a rocket again this week after approval leading to an amazing July for all the shareholders.
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
Saturday, June 23, 2012
New Business Opportunities in China, IC Places inc. to produce content for massive China medium?
You heard it here first! Sierra World Equity Review ventures that IC Places will be one of the smaller US companies tapping into the incredible opportunities opening in China.
A new rising middle class in China as well as a rich and mega rich class have opened many new opportunities for US companies looking to skyrocket their value by tapping into the massive Chinese market. This trend is expected to continue and dynamic innovative US companies are lining up to capitalize on the huge China market.
"City on a Plate: Shanghai"
IC Places would reap the benefits of entry into the Chinese market, more and more Chinese are now optimistic about moving into the middle class and domestic travel and tourism in China will soon equal that of the United States. More recent surveys have shown that Chinese consumers now desire such things as quality, style and thus foreign brand name have become far more important.
N01-0121500 Beijing 2008 Complete Opening Ceremony
The attitudes and behavior of China's younger generation are one of conspicuous consumption of American products such as Hollywood movies and generally all things American. IC Places could really hit this out of the ballpark!
"Shanghai II Framed Artwork"
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
A new rising middle class in China as well as a rich and mega rich class have opened many new opportunities for US companies looking to skyrocket their value by tapping into the massive Chinese market. This trend is expected to continue and dynamic innovative US companies are lining up to capitalize on the huge China market.
"City on a Plate: Shanghai"
IC Places would reap the benefits of entry into the Chinese market, more and more Chinese are now optimistic about moving into the middle class and domestic travel and tourism in China will soon equal that of the United States. More recent surveys have shown that Chinese consumers now desire such things as quality, style and thus foreign brand name have become far more important.
N01-0121500 Beijing 2008 Complete Opening Ceremony
The attitudes and behavior of China's younger generation are one of conspicuous consumption of American products such as Hollywood movies and generally all things American. IC Places could really hit this out of the ballpark!
"Shanghai II Framed Artwork"
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
Is Tyco International (TYC) pursuing a buyout of KMA Global Solutions (KMAG)
Sierra World Equity Review would not be surprised to see Tyco International (TYC) involved in a buyout of KMA Global Solutions. Sensormatic Retail Solutions is the global leader of Source Tagging and is part of the Tyco family of companies.
Sierra World Equity Review is always on the cutting edge of industry news.
KMA Global Solutions (KMAG) has shown tremendous potential in it's field of Source Tagging and has a lucrative upside making it a desirable asset for a larger player in the industry such as Tyco International.
TYCO ADHESIVES 617001 Nashua Premium Foil Tapes - 2"x50 yds Aluminum
Over 80 percent of world's top 200 retailers that use EAS rely on Sensormatic Retail Solutions, which include EAS, source-tagging, data analytics and in-store, item-level intelligence applications.
The industry-leading Sensormatic Retail Solutions portfolio offers vital loss prevention and operational improvement technologies and solutions. Backed by more than 1,500 patents, the Sensormatic solutions portfolio is sold through ADT and authorized business partners around the world
Wireless Motion Alert Add-on Sensor - Monitors & Intercoms
KMA Global Solutions is the new up and comer, it's first quarter earnings for 2012 rose 611% with a profit of $50,788 for the quarter. Sales continue to be strong and growing and the company is carving it's own substantial share of the Source Tagging industry.
"Kma Team Sticker"
Sierra World Equity Review anticipates that a buyout offer from the Tyco International would be very hard to resist for KMA Global Solutions and most certainly the big winners would also be the shareholders of KMA Global solutions.
Sierra World Equity Review will continue to highlight Tyco International and KMA Global Solutions going forward. Check back here for the latest updates and reports from Sierra World Equity Review.
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
Sierra World Equity Review is always on the cutting edge of industry news.
KMA Global Solutions (KMAG) has shown tremendous potential in it's field of Source Tagging and has a lucrative upside making it a desirable asset for a larger player in the industry such as Tyco International.
TYCO ADHESIVES 617001 Nashua Premium Foil Tapes - 2"x50 yds Aluminum
Over 80 percent of world's top 200 retailers that use EAS rely on Sensormatic Retail Solutions, which include EAS, source-tagging, data analytics and in-store, item-level intelligence applications.
The industry-leading Sensormatic Retail Solutions portfolio offers vital loss prevention and operational improvement technologies and solutions. Backed by more than 1,500 patents, the Sensormatic solutions portfolio is sold through ADT and authorized business partners around the world
Wireless Motion Alert Add-on Sensor - Monitors & Intercoms
KMA Global Solutions is the new up and comer, it's first quarter earnings for 2012 rose 611% with a profit of $50,788 for the quarter. Sales continue to be strong and growing and the company is carving it's own substantial share of the Source Tagging industry.
"Kma Team Sticker"
Sierra World Equity Review anticipates that a buyout offer from the Tyco International would be very hard to resist for KMA Global Solutions and most certainly the big winners would also be the shareholders of KMA Global solutions.
Sierra World Equity Review will continue to highlight Tyco International and KMA Global Solutions going forward. Check back here for the latest updates and reports from Sierra World Equity Review.
Sierra World Equity Review currently hold no positions in any of the companies mentioned in this report.
Is Cannabis Science Inc. poised to announce European joint venture with Dutch Passion in Amsterdam
With Cannabis Science Inc. moving to expand internationally is an announcement of a joint venture with leading Cannabis Seed developer Dutch Passion of Amsterdam imminent.
Sierra World Equity Review projects that Cannabis Science Inc. (CBIS) will be entering into a joint venture with the Dutch Passion Seed Company located in Amsterdam.
Sierra World Equity Review ventures that this is part of Cannabis Science Inc. move to expand internationally and generate multiple new revenue streams that will add massive value to the company while simultaneously gaining it exposure on the international stage. Working with a respected and established Cannabis Seed company such as Dutch Seed Passion who since 1987 have been developing, upgrading, producing and selling seeds would be a substantial coup for the company and one that would open many new doors.
"Cannabis Plant Framed Tile"
Sierra World Equity Review predicts in the event of such a joint venture both the Dutch Seed Company and Cannabis Science Inc. would be mutual winners...as well as the share holders in Cannabis Science Inc. (CBIS).
"Yes We Cannabis Underwear"
Sierra World Equity Review will continue to highlight Cannabis Science moving forward. Check back for further updates.
Ferry Morse Seed Company Windowsill Greenhouse Pack Of 30 - 5042
Thursday, June 21, 2012
All American Pet Company (AAPT) is hiring in Shawnee_Watch For Supervalu (SVU) Buyout
Sierra World Equity Review can see why the Mayor of Shawnee KS was so happy to get All American Pet Company to relocate to Shawnee. The initial estimates of bringing 80 new jobs to the Shawnee area appear in Sierra's estimate to be conservative. With several innovative and patent pending products soon to be on the shelves at retail stores across the nation followed by the international distribution announcements, expect the employment rate in the Shawnee to fall as many more positions are created. Another Stock catching Sierra and the teams eye is Supervalu (SVU). Sierra predicts that SVU is an excellent buyout candidate and that in the next few months expect to see more people catch onto this, as they do just watch the pps rise, remember you heard it first from Sierra!
BREAKING NEWS: All American Pet Company to announce Distribution Agreements
Sierra World Equity Review predicts that All American Pet Company (AAPT) is on the verge of announcing it's distribution agreements to brick and mortar stores in the United States. Sierra ventures that the official PR from the company will prior to the end of June.
"Memory Sleeper Dog Bed"
"Memory Sleeper Dog Bed"
RESULTS for Friday June 22nd- Be on the WINNING team Sierra's new BUY or SELL lists
RESULTS for Friday June 22nd 2012.
Sierra World Equity Review uses an advanced complex blend of Japanese technical indicators to continuously get the most ACCURATE results. Best of all we do not charge you for them, they are free....how great is that!
Here are our picks and RESULTS for Friday June 22nd 2012.
Sierra World Equity Review uses an advanced complex blend of Japanese technical indicators to continuously get the most ACCURATE results. Best of all we do not charge you for them, they are free....how great is that!
Here are our picks and RESULTS for Friday June 22nd 2012.
BUY LIST: THE WINNERS ARE:
Great Wall Builders (GWBU) UP 10.53%
IC Places, Inc. (ICPA) UP 5.35%
Aisystems, Inc. (ASYI) DOWN 50%
Bebida Beverage Company (BBDA) UP 33.33%
All American Pet Company, Inc. (AAPT) UP 2.94%
Apple Inc (AAPL) UP 0.77%
Advanced Micro Devices (AMD) UP 0.17%
Mimvi Inc. (MIMV) up 9.26%
Net Savings Link Inc.(NSAV) UP 40.54%
Red Hat Inc. (RHT) UP 3.79%
SPDR TR S&P 500 ETF Trust (SPY) UP 0.77%
Verizon Communications (VZ) UP 1.43%
Highline Technical Innovations. Inc. (HLNT) UP 28.05%
Microsoft Corp. (MSFT) UP 1.87%
JP Morgan Chase (JPM) UP 1.35%
Google Inc. (GOOG) UP 1.11%
Bank of America (BAC) UP 1.53%
Bed Bath & Beyond Inc. (BBBY) UP 0.04%
CitiGroup Inc. (C) UP 0.57%
Chesapeake Energy Corp. (CHK) UP 2.70%
SELL List: THE LOSERS ARE: (Read them and WEEP...lol)
KMA Global Solutions (KMAG) DOWN 7.32%
Oxigene Inc. (OXGN) DOWN 1.43%
WebSafety Inc. (WBSI) DOWN 4.93%
Boyd Gaming Corp. (BYD) DOWN 2.42%
AGR Tools, Inc. (AGRT) DOWN 15.97%
Entest BioMedical Inc. (ENTB) DOWN 16.88%
Uni Core Hldngs (UCHC) DOWN 25%
Aisystems, Inc. (ASYI) DOWN 50%
Oxigene Inc. (OXGN) DOWN 1.43%
WebSafety Inc. (WBSI) DOWN 4.93%
Boyd Gaming Corp. (BYD) DOWN 2.42%
AGR Tools, Inc. (AGRT) DOWN 15.97%
Entest BioMedical Inc. (ENTB) DOWN 16.88%
Uni Core Hldngs (UCHC) DOWN 25%
Aisystems, Inc. (ASYI) DOWN 50%
Arena Pharm.Inc. (ARNA) DOWN 15.41%
Uni Core Hldngs (UCHC) DOWN 25%
Energy Edge Technologies Corp. (EEDG) DOWN 10.26%
Atrinsic, Inc. (ATRNQ) DOWN 3.45%
Imaging Diagnostic Systems (IMDS) DOWN 20%
Triton Dist. Systems (TTDZ) DOWN 18.18%
Elite Pharmaceuticals (ELTP) DOWN 4.58%
Arena Pharm.Inc. (ARNA) DOWN 15.41%
Herborium Group, Inc. (HBRM) DOWN 6.90%
Subscribe to:
Posts (Atom)